Biocryst Pharmaceuticals Inc. (BCRX)

New York State Common Retirement Fund Sells 17821 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World

Defense World

Is the Options Market Predicting a Spike in BioCryst Pharmaceuticals (BCRX) Stock? - Yahoo Lifestyle UK

Yahoo Lifestyle UK

BioCryst Pharmaceuticals Shares Rise 20% Following Disclosure of Executive Share Purchases - Marketscreener.com

Marketscreener.com

Biocryst Pharmaceuticals exec buys $164k in company stock - Investing.com Canada

Investing.com Canada

Biocryst Pharmaceuticals CEO buys $166,500 in company stock By Investing.com - Investing.com Australia

Investing.com Australia

Biocryst Pharmaceuticals director buys $120k in stock By Investing.com - Investing.com Australia

Investing.com Australia

Biocryst Pharmaceuticals executive buys $27,650 in stock By Investing.com - Investing.com Australia

Investing.com Australia

BioCryst Pharmaceuticals CFO buys $202k in company stock - Investing.com Australia

Investing.com Australia

Biocryst Pharmaceuticals executive buys $27,650 in stock By Investing.com - Investing.com Canada

Investing.com Canada

Biocryst Pharmaceuticals CEO buys $166,500 in company stock By Investing.com - Investing.com Canada

Investing.com Canada

Steven K. Galson Purchases 21,940 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Stock - MarketBeat

MarketBeat

Biocryst Pharmaceuticals exec buys $164k in company stock - Investing.com

Investing.com

BioCryst Pharmaceuticals (NASDAQ:BCRX) Shares Gap Up Following Insider Buying Activity - MarketBeat

MarketBeat

Insider Buying: Chief R&D Officer Helen Thackray Acquires 30000 Shares of BioCryst ... - Yahoo Finance

Yahoo Finance

Director Steven Galson Acquires 21,940 Shares of BioCryst Pharmaceuticals Inc (BCRX) - Yahoo Finance

Yahoo Finance

Insider Buying: Charles Gayer Acquires 30,000 Shares of BioCryst Pharmaceuticals Inc (BCRX) - Yahoo Finance

Yahoo Finance

Insider Buying: CFO Anthony Doyle Acquires Shares of BioCryst Pharmaceuticals Inc (BCRX) - Yahoo Finance

Yahoo Finance

BioCryst stock spikes on insider purchases (NASDAQ:BCRX) - Seeking Alpha

Seeking Alpha

Biocryst Pharmaceuticals executive buys $27,650 in stock By Investing.com - Investing.com

Investing.com

Biocryst Pharmaceuticals CFO purchases $202k in company stock - Investing.com

Investing.com

BioCryst Pharmaceuticals CFO buys $202k in company stock - Investing.com

Investing.com

Biocryst Pharmaceuticals CFO purchases $202k in company stock - Investing.com UK

Investing.com UK

Biocryst Pharmaceuticals director buys $120k in stock By Investing.com - Investing.com UK

Investing.com UK

Biocryst Pharmaceuticals executive buys $27,650 in stock By Investing.com - Investing.com UK

Investing.com UK

Biocryst Pharmaceuticals CEO buys $166,500 in company stock By Investing.com - Investing.com UK

Investing.com UK

Biocryst Pharmaceuticals exec buys $164k in company stock - Investing.com UK

Investing.com UK

What Kind Of Shareholders Hold The Majority In BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) Shares? - Yahoo New Zealand News

Yahoo New Zealand News

BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology - GlobeNewswire

GlobeNewswire

BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology

GlobeNewswire Inc.

Mexico approves BioCryst's HAE drug ORLADEYO - Investing.com India

Investing.com India

BioCryst Pharmaceuticals (BCRX) in Focus: Stock Moves 8.5% Higher - Yahoo Movies UK

Yahoo Movies UK

BioCryst (BCRX) Provides Updates on Galidesivir, Shares Fall - Yahoo Singapore News

Yahoo Singapore News

Is the Options Market Predicting a Spike in BioCryst Pharmaceuticals (BCRX) Stock? - Yahoo Lifestyle UK

Yahoo Lifestyle UK

Mexico approves BioCryst's HAE drug ORLADEYO By Investing.com - Investing.com

Investing.com

Mexico approves BioCryst's HAE drug ORLADEYO By Investing.com - Investing.com UK

Investing.com UK

ORLADEYO® (berotralstat) Approved in Mexico - GlobeNewswire

GlobeNewswire

ORLADEYO® (berotralstat) Approved in Mexico - Yahoo Finance

Yahoo Finance

Are Institutions Heavily Invested In BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) Shares? - Yahoo News UK

Yahoo News UK

Los Angeles Capital Management LLC Has $319000 Stock Position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World

Defense World

BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) institutional shareholders had a great week as one-year returns ... - Yahoo Canada Shine On

Yahoo Canada Shine On

BioCryst Pharmaceuticals, Inc. to Post Q2 2024 Earnings of ($0.14) Per Share, HC Wainwright Forecasts (NASDAQ ... - Defense World

Defense World

Research Analysts Issue Forecasts for BioCryst Pharmaceuticals, Inc.'s Q2 2024 Earnings (NASDAQ:BCRX) - MarketBeat

MarketBeat

BioCryst Presents New Real-world Evidence Showing Significant Reductions in Healthcare Resource Utilization ... - GlobeNewswire

GlobeNewswire

Analysts Are Updating Their BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Estimates After Its First-Quarter Results - Yahoo Finance

Yahoo Finance

Analysts Are Updating Their BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Estimates After Its First-Quarter Results - Yahoo Finance

Yahoo Finance

FY2028 EPS Estimates for BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Reduced by Analyst - Defense World

Defense World

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Forecasted to Earn FY2028 Earnings of $1.31 Per Share - MarketBeat

MarketBeat

BioCryst Pharmaceuticals (NASDAQ:BCRX) Receives Buy Rating from Needham & Company LLC - Defense World

Defense World

BioCryst Pharmaceuticals (NASDAQ:BCRX) Receives Buy Rating from Needham & Company LLC - Defense World

Defense World

BioCryst Pharmaceuticals (NASDAQ:BCRX) Issues Earnings Results - MarketBeat

MarketBeat